The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age - Trial 2015-004872-31
Access comprehensive clinical trial information for 2015-004872-31 through Pure Global AI's free database. This phase not specified trial is sponsored by GlaxoSmithKline and is currently status unknown. The study focuses on Bipolar Disorder.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
GlaxoSmithKline
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
- Subject has been diagnosed with a primary Axis I disorder (with the exception of bipolar I disorder, ADHD, anxiety disorders, oppositional defiant disorder, or conduct disorder) or any Axis II disorder.
ICD-10 Classifications
Data Source
EU Clinical Trials Register
2015-004872-31
Non-Device Trial